Stocks VRSN Financial statements
Financial statementsVERISIGN INC/CA financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data VERISIGN INC/CA files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,142 | 1,165 | 1,215 | 1,232 | 1,265 | 1,328 | 1,425 | 1,493 | 1,557 | 1,657 |
| Cost of revenue | 198 | 193 | 192 | 180 | 180 | 192 | 201 | 197 | 191 | 196 |
| Gross profit | 944 | 972 | 1,023 | 1,051 | 1,085 | 1,136 | 1,224 | 1,296 | 1,366 | 1,460 |
| Research and development | 59.1 | 52.3 | 57.9 | 60.8 | 74.7 | 80.5 | 85.7 | 91 | 96.7 | 104 |
| Selling, general and administrative | 186 | 188 | 195 | 204 | 211 | 236 | ||||
| Selling and marketing | 80.3 | 82 | 64.9 | 46.6 | 36.8 | 39.9 | ||||
| General and administrative | 118 | 130 | 133 | 138 | 149 | 148 | ||||
| Operating expenses | 482 | 493 | 499 | 536 | ||||||
| Operating income | 687 | 708 | 767 | 806 | 824 | 867 | 943 | 1,001 | 1,058 | 1,121 |
| Interest expense | 116 | 136 | 115 | 90.6 | 90.2 | 83.3 | 75.3 | 75.3 | 75.3 | 77 |
| Interest income | 6.19 | 17.9 | 26.5 | 26.6 | 7.8 | 0.6 | 14.9 | 46.1 | 37.4 | 26.5 |
| Other non-operating income | 10.2 | 27.6 | 77 | 43.3 | 16.2 | -1.3 | 12.4 | 51.2 | 39 | 24.5 |
| Pre-tax income | 581 | 599 | 730 | 759 | 750 | 782 | 880 | 977 | 1,022 | 1,069 |
| Income tax | 141 | 142 | 147 | 146 | -64.7 | -2.6 | 206 | 159 | 236 | 243 |
| Net income | 441 | 457 | 582 | 612 | 815 | 785 | 674 | 818 | 786 | 826 |
| EBITDA | 745 | 758 | 816 | 852 | 871 | 915 | 990 | 1,045 | 1,095 | 1,152 |
| EPS, basic | 4.12 | 4.56 | 5.13 | 5.17 | 7.08 | 7.01 | 6.24 | |||
| EPS, diluted | 3.42 | 3.68 | 4.75 | 5.15 | 7.07 | 7.00 | 6.24 | |||
| Shares, basic (weighted) | 107 | 100 | 113 | 119 | 115 | 112 | 108 | 103 | 98.1 | 93.5 |
| Shares, diluted (weighted) | 129 | 124 | 123 | 119 | 115 | 112 | 108 | 104 | 98.2 | 93.8 |
| Dividend per share | 0.00 | 0.00 | 2.31 |
Balance sheet
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 232 | 466 | 357 | 508 | 401 | 224 | 374 | 240 | 207 | 308 |
| Short-term investments | 1,566 | 1,949 | 912 | 710 | 766 | 982 | 607 | 686 | 393 | 273 |
| Receivables | 13.1 | 5.11 | 6.03 | 1.52 | 4.64 | 5.3 | 6.2 | 6.3 | 5.6 | 7.7 |
| Other current assets | 1.67 | 4.16 | 2.08 | 1.64 | 2.25 | 0.9 | 58.3 | 61.9 | 63.9 | 72 |
| Total current assets | 1,842 | 2,446 | 1,317 | 1,279 | 1,218 | 1,269 | 1,039 | 988 | 664 | 653 |
| Property, plant and equipment | 266 | 264 | 254 | 250 | 246 | 251 | 232 | 233 | 225 | 214 |
| Lease right-of-use assets | 0 | 9.13 | 11.3 | 8.4 | 7.2 | |||||
| Goodwill | 52.5 | 52.5 | 52.5 | 52.5 | 52.5 | 52.5 | 52.5 | 52.5 | 52.5 | 52.5 |
| Other non-current assets | 19.2 | 18.6 | 41 | 39.8 | 38 | 35.7 | 30.6 | 29 | 39.4 | 28.8 |
| Total assets | 2,335 | 2,941 | 1,915 | 1,854 | 1,767 | 1,984 | 1,733 | 1,749 | 1,407 | 1,326 |
| Accounts payable | 19.5 | 10.5 | 17.3 | 15.9 | 12.3 | 9 | 9.8 | 12.5 | 10.6 | 13.8 |
| Deferred revenue | 688 | 713 | 732 | 755 | 780 | 847 | 890 | 931 | 974 | 1,035 |
| Total current liabilities | 1,522 | 1,561 | 948 | 965 | 989 | 1,074 | 1,117 | 1,189 | 1,531 | 1,333 |
| Long-term debt | 1,237 | 1,783 | 1,785 | 1,788 | 1,790 | 1,786 | 1,788 | 1,790 | 1,493 | 1,788 |
| Lease liabilities | 0 | 4.56 | 5.16 | |||||||
| Other non-current liabilities | 117 | 128 | 282 | 313 | 95.5 | 78.6 | 62.1 | 36.3 | 10.1 | 9.4 |
| Total liabilities | 3,535 | 4,201 | 3,300 | 3,344 | 3,157 | 3,244 | 3,296 | 3,330 | 3,364 | 3,480 |
| Paid-in capital | 16,987 | 16,437 | 15,707 | 14,990 | 14,275 | 13,620 | 12,645 | 11,808 | 10,645 | 9,624 |
| Retained earnings | -18,185 | -17,695 | -17,090 | -16,477 | -15,663 | -14,878 | -14,204 | -13,386 | -12,601 | -11,775 |
| Other comprehensive income | -3.45 | -2.94 | -2.81 | -2.62 | -2.76 | -2.8 | -2.7 | -2.6 | -2.5 | -2.7 |
| Shareholders' equity | -1,201 | -1,260 | -1,385 | -1,490 | -1,390 | -1,261 | -1,562 | -1,581 | -1,958 | -2,154 |
| Total equity | -1,201 | -1,260 | -1,385 | -1,490 | -1,390 | -1,261 | -1,562 | -1,581 | -1,958 | -2,154 |
| Total liabilities and equity | 2,335 | 2,941 | 1,915 | 1,854 | 1,767 | 1,984 | 1,733 | 1,749 | 1,407 | 1,326 |
| Shares outstanding | 103 | 97.6 | 120 | 117 | 113 | 111 | 105 | 101 | 95 | 91.9 |
Cash flow statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 441 | 457 | 582 | 612 | 815 | 785 | 674 | 818 | 786 | 826 |
| Depreciation and amortization | 58.2 | 49.9 | 48.4 | 46.3 | 46.4 | 47.9 | 46.9 | 44.1 | 36.9 | 31.2 |
| Stock-based compensation | 50 | 52.9 | 52.5 | 50.6 | 48.2 | 53.4 | 58.6 | 59.7 | 61.1 | 69.7 |
| Deferred income tax | 86.2 | 109 | -29.4 | 38.7 | 19.6 | -162 | -6.7 | -52.6 | 13.7 | 47.3 |
| Change in receivables | -0.87 | |||||||||
| Change in payables | 40.2 | 15.5 | -2.13 | -0.02 | 2.2 | 1.4 | -13.3 | -2.2 | -28.9 | 42.7 |
| Cash from operations | 693 | 703 | 698 | 754 | 730 | 807 | 831 | 854 | 903 | 1,091 |
| Capital expenditures | -26.6 | -49.5 | -37 | -40.3 | -43.4 | -53 | -27.4 | -45.8 | -28.1 | -22.8 |
| Purchases of investments | -3,691 | -4,930 | -2,977 | -2,031 | -2,355 | -2,871 | -1,338 | -1,331 | -881 | -572 |
| Sales and maturities of investments | 3,818 | 4,562 | 4,032 | 2,248 | 2,306 | 2,655 | 1,722 | 1,279 | 1,195 | 704 |
| Cash from investing | -42.7 | -405 | 1,070 | 167 | -72.3 | -269 | 356 | -97.4 | 286 | 109 |
| Debt issued | 0 | 543 | 0 | 0 | ||||||
| Debt repaid | 0 | 0 | -500 | |||||||
| Share buybacks | -662 | -621 | -638 | -783 | -778 | -723 | -1,048 | -901 | -1,226 | -882 |
| Dividends paid | 0 | 0 | -215 | |||||||
| Cash from financing | -649 | -65.1 | -1,875 | -770 | -765 | -719 | -1,036 | -890 | -1,222 | -1,103 |
| Exchange rate effect | -0.5 | 1.29 | -0.96 | 0.06 | 0 | -0.7 | -0.8 | -0.1 | -0.8 | 0 |
| Net change in cash | 0.95 | 234 | -108 | 151 | -107 | -182 | 150 | -134 | -33.4 | 97.4 |
| Free cash flow | 666 | 653 | 661 | 714 | 687 | 754 | 804 | 808 | 875 | 1,068 |
| Interest paid | 116 | 117 | 118 | 87.7 | 87.4 | 85.6 | 72.8 | 72.8 | 72.8 | 78.7 |
| Income taxes paid | 14.3 | 28.3 | 84.9 | 90 | 133 | 178 | 212 | 240 | 231 | 202 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 88.5% | Gross profit / revenue. |
| Operating margin | 67.9% | Operating income / revenue. |
| EBITDA margin | 69.4% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 64.6% | Pre-tax income / revenue. |
| Net margin | 49.8% | Net income / revenue. |
| FCF margin | 62.4% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 64.5% | Cash from operations / revenue. |
| Effective tax rate | 23.0% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on assets (ROA) | 47.1% | Net income / average total assets. |
| R&D / revenue | 6.3% | Research and development expense / revenue. |
| SG&A / revenue | 14.3% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 4.4% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 2.1% | Capital expenditures / revenue. |
| D&A / revenue | 1.6% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 6.4% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 5.2% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 5.5% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 6.9% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 6.1% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 6.1% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 5.9% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 5.9% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 6.3% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 5.2% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 5.2% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 5.8% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | 5.1% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 7.0% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 0.3% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 20.9% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 9.5% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 8.4% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 22.2% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 10.0% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 9.2% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -5.7% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -8.5% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -5.6% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -4.5% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -4.6% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -4.0% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 0.59x | Current assets / current liabilities. |
| Quick ratio | 0.55x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.54x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 225.0% | Total liabilities / total assets. |
| Interest coverage | 15.3x | Operating income / interest expense. |
| Working capital | -$776.8M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 2.9% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$2.31B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.95x | Revenue / average total assets. |
| Fixed asset turnover | 7.50x | Revenue / average property, plant and equipment. |
| Receivables turnover | 180x | Revenue / average receivables. |
| Days sales outstanding | 2 days | 365 x average receivables / revenue. |
| Days payables | 24 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | 125.4% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 3.2% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $9.33 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $18.75 | Revenue / diluted weighted shares. |
| FCF per share | $11.70 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $12.09 | Cash from operations / diluted weighted shares. |
| Book value per share | -$24.93 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$25.52 | Tangible book value / shares outstanding. |
| Cash per share | $11.44 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 34.2% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 27.3% | Dividends paid / free cash flow, when free cash flow is positive. |
| Buybacks / FCF | 84.4% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $25.94B | Share price x shares outstanding. |
| Enterprise value | $24.90B | Market cap + total debt - cash - short-term investments. |
| P/E | 30.5x | Market cap / net income. Only when net income is positive. |
| P/S | 15.2x | Market cap / revenue. |
| P/FCF | 24.3x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 23.6x | Market cap / cash from operations, when positive. |
| EV/Sales | 14.6x | Enterprise value / revenue. |
| EV/EBIT | 21.5x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 21.0x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 23.4x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 4.1% | Free cash flow / market cap. |
| Earnings yield | 3.3% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 1.1% | Dividends paid over the period / market cap. |
| Shareholder yield | 4.6% | (Dividends paid + share buybacks) / market cap. |
What was VERISIGN INC/CA's revenue in fiscal 2025?
VERISIGN INC/CA reported revenue of $1.66B for fiscal 2025, 6.4% higher than the year before.
Was VERISIGN INC/CA profitable in fiscal 2025?
Yes. Net income was $825.7M, a net margin of 49.8%.
How much free cash flow did VERISIGN INC/CA generate in fiscal 2025?
Cash from operations of $1.09B minus capital expenditures of $22.8M left free cash flow of $1.07B.